Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.6.2 was added to the history, and the older v3.6.0 entry was removed, updating the record's version history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history now includes a 'No longer looking for participants' entry, indicating recruitment for the study has closed. It also adds a 'Revision: v3.6.0' entry and removes the previous 'Revision: v3.5.5', updating the version trail.SummaryDifference0.3%

- Check25 days agoChange DetectedRevision: v3.5.5 was added to the history, replacing the previous v3.5.4. It represents a minor update to the page's revision log rather than substantive changes.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a backend/platform update rather than content changes to the record history.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the Record History page, indicating a new version of the study record was published.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.